Metabolic Testing Market is valued at USD 540.91 Million in 2020 and expected to reach USD 903.26 Million by 2027 with the CAGR of 7.60% over the forecast period.
Metabolic Testing Market: Global Size, Trends, Competitive, and Historical & Forecast Analysis, 2021-2027– Increased consumption of unhealthy food, pollution, stressful life and unhealthy lifestyle are some of the factors driving the growth of Global Metabolic Testing Market.
Metabolic tests are used for measuring the speed at which calories are burned by patient’s body. These are also used for measuring oxygen used during rest and physical activities. Several years back, metabolic testing was only available in expensive hospital or laboratory settings. Now a days, gyms and health clubs started offering metabolic evaluations using cost-efficient equipment. The procedures and equipment which are utilized in a gym or health spa setting are often almost like the protocols and equipment utilized in a hospital setting. Following are some tests which are usually performed. Resting metabolic rate (RMR) test was the first one performed. This test provides an estimate of the number of calories burned by body when human body is resting. VO2 max test: This test gives information regarding the intensity levels at which oxygen is used by body. It tells how efficient human body is at burning fat. Another one is Lactate threshold test which provides data regarding the intensity level where patient’s body can no longer supply an appropriate amount of oxygen for maximum performance. This is where fatigue sets in and lactate production peaks.
Global Metabolic Testing market is segmented on the basis of type, application, technology, end-user and region & country level. On the basis of type, the market is segmented into CPET systems, metabolic carts, body composition analyzers, ECGs/EKGs attachable to CPET systems and software. On the basis of application, the market is segmented into lifestyle diseases, critical care, human performance testing, dysmetabolic syndrome X, metabolic disorders and other. On the basis of technology, the market is segmented into VO2 max analysis, RMR analysis and body composition analysis. On the basis of end-user, the market is segmented into hospitals, laboratories, sports training centers, gyms and other.
The regions covered in this Metabolic Testing Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of metabolic testing is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Centogene Launched CentoMetabolic Panel for Integrated Multiomic Testing for Metabolic Diseases
April 10th, 2019; Centogene Company announced the launch of CentoMetabolic, a first-line test for the widest range of rare genetic metabolic diseases. By combining genetic and biochemical testing, CentoMetabolic allows for immediate confirmation and for several diagnoses a far better understanding of the course of the disease, enhanced treatment monitoring, and tailored treatment guidance. The medical diagnosis of a suspected genetic disease often requires the analysis of multiple genes, for instance conditions that show similar or overlapping phenotypes. CentoMetabolic includes as many as 166 genes. The panel was developed specifically for patients suspected to possess a disorder or presenting complex, overlapping symptoms, a metabolic crisis or neurological conditions of unknown etiology. CentoMetabolic provides short turn-around-times targeting critically ill patients, and includes enzyme-activity testing where applicable, and a proprietary selection of biomarkers that is continually updated.
Increased fast social life and unhealthy lifestyle are the main factors behind overweightness and driving the growth of metabolic testing market. In addition, consumption of snacks and fat included foods and increasing disposable income are also supplementing the market growth. All this lead to the lifestyle diseases like cancer, chronic disorders etc. as per WHO Cancer is the second leading cause of death globally, and is responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths is due to cancer. Approximately 70% of deaths from cancer occur in low- and middle-income countries.
However, lack of awareness in other middle income and below the line countries may hamper the market growth. In spite of that, technology advancement, increasing standards of hospital services and increasing population are some factors which can provide more opportunities for the further growth of the market.
North America is expected to dominate the global metabolic testing market of due to the increasing cases of lifestyle diseases in this region. Obesity is one of the major risk factors for a number of chronic diseases including diabetes, cardiovascular diseases and cancer. In 2018, 34.2 million Americans, or 10.5% of the population, had diabetes. Nearly 1.6 million Americans have type-1 diabetes, including about 187,000 children and adolescents. Europe is the second largest market in which CVD accounts for 45% of all deaths in Europe and 37% of all deaths in the Europe. Asia Pacific is a fastest growing market metabolic testing. Only Asia comprises more than 4.5 billion people which is 60% of the world population living in 49 different nations have the economic power. Asia pacific is the growing largest market for metabolic testing followed by Europe.
|Years :||2019||Market Size in 2019:||US$ 467.2 Million|
|Market Historical Analysis:||2015-2019||Forecast Analysis:||2020-2026|
|Forecast Period CAGR %:||7.6%||Market Size Expected to reach in 2026:||US$ 780.2 Million|
|Pages:||200||Tables, Charts & Figures:||170|
|Top Companies:||Microlife Medical Home Solutions, Inc., Parvo Medics, AEI Technologies, Inc., KORR Medical Technologies, Inc., OSI Systems, Inc., General Electric Company, Geratherm medical AG, CORTEX Biophysik GmbH, COSMED, MGC Diagnostic Corporation and CareFusion Corporation and others.|
|Market Segmentation:||Product Type, Application, Technology Type, End-User|
|Regional Analysis:||North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa|
By Product Type:
By Application Analysis:
Regional & Country Analysis
Middle East and Africa
Frequently Asked Questions (FAQ) :